Oncternal Therapeutics Inc (ONCT) Stock Cash Flow
NASDAQ:ONCT - Nasdaq - US68236P2065 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -34.58M | -39.48M | -44.17M | -31.33M | -17.23M | |||
| Depreciation Amortization | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 1.99M | 1.27M | -69.00K | -1.30M | -1.68M | |||
| Other non cash items | 5.95M | 6.04M | 7.54M | 6.04M | 1.41M | |||
| OPERATING CASH FLOW | -26.63M | -32.16M | -36.70M | -26.59M | -17.50M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | 24.87M | 651.00K | -26.50M | N/A | 0.00 | |||
| INVESTING CASH FLOW | 24.87M | 651.00K | -26.50M | N/A | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 301.00K | |||
| Stock Issued/Repurchased | -88.00K | 1.07M | 9.58M | 617.00K | 113.88M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -88.00K | 1.07M | 9.58M | 617.00K | 114.18M | |||
| CHANGE IN CASH | -1.85M | -30.45M | -53.62M | -25.97M | 96.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -26.63M | -32.16M | -36.70M | -26.59M | -17.50M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -26.63M | -32.16M | -36.70M | -26.59M | -17.50M | |||
All data in USD